Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis

Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis

Little is known about the efficacy and safety of the anti-interleukin 5 monoclonal antibody mepolizumab (MPZ) in patients with eosinophilic granulomatosis with polyangiitis (EGPA) in real-life. We thus evaluated disease activity, damage and disease-related complications in 14 patients with EGPA rece...

Full description

Bibliographic Details
Main Authors:	Giuseppe A. Ramirez, Adriana Cariddi, Silvia Noviello, Corrado Campochiaro, Valentina Canti, Luca Moroni, Mona-Rita Yacoub, Elena M. Baldissera, Enrica P. Bozzolo, Lorenzo Dagna
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Clinical Immunology Communications
Subjects:	Eosinophilic granulomatosis with polyangiitis Mepolizumab Asthma Corticosteroids Infections
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772613422000026

Similar Items

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
by: Masanobu Ueno, et al.
Published: (2021-03-01)

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
by: Masanobu Ueno, et al.
Published: (2022-06-01)

Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan
by: Takashi Yamane, et al.
Published: (2023-06-01)

Improvement of peripheral neuropathy in a patient with antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis by additional mepolizumab
by: Yoshiro Kai, et al.
Published: (2022-02-01)

Switching from omalizumab to mepolizumab therapy improved extra‐pulmonary abdominal and cutaneous vasculitis symptoms in a patient with eosinophilic granulomatosis with polyangiitis
by: Yu‐Hsuan Chen, et al.
Published: (2022-01-01)

A case of refractory peripheral neuropathy associated with eosinophilic granulomatosis with polyangiitis with successful tapering of systemic corticosteroid and reduced dosing frequency of high-dose intravenous immunoglobulin after combined use of mepolizumab
by: Kentaro Kawate, et al.
Published: (2024-04-01)

Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis
by: Nami Masumoto, et al.
Published: (2023-05-01)

INTERLEUKIN-5 IS A NEW TARGET IN THE TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
by: T. V. Beketova, et al.
Published: (2020-06-01)

Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations
by: Ryu Watanabe, et al.
Published: (2023-09-01)

Benralizumab monotherapy was insufficient to induce remission in patients with active eosinophilic granulomatosis with polyangiitis
by: Osamu Matsuno, et al.
Published: (2022-01-01)

Recurrent atelectasis and brain infarction in a patient with anti-neutrophil antibody negative eosinophilic granulomatosis with polyangiitis: a case report
by: Ken-ei Sada, et al.
Published: (2021-09-01)

Novel Targets for Drug Use in Eosinophilic Granulomatosis With Polyangiitis
by: Martina Uzzo, et al.
Published: (2021-11-01)

A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis
by: Michele V. Quan, et al.
Published: (2018-11-01)

Endobronchial Lesion in Eosinophilic Granulomatosis with Polyangiitis
by: Guan-Liang Chen, et al.
Published: (2017-12-01)

Gastrointestinal Involvement of Eosinophilic Granulomatosis with Polyangiitis with Histological Evidence of Treatment Response
by: Mark Lai, et al.
Published: (2023-03-01)

Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
by: Santi Nolasco, et al.
Published: (2023-06-01)

Clinical implications of peripheral eosinophil count at diagnosis in patients newly diagnosed with microscopic polyangiitis and granulomatosis with polyangiitis
by: Jang Woo Ha, et al.
Published: (2023-12-01)

Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
by: Charlene Desaintjean, et al.
Published: (2024-03-01)

Pancarditis as the Clinical Presentation of Eosinophilic Granulomatosis with Polyangiitis: A Multimodality Approach to Diagnosis
by: Michele Lioncino, et al.
Published: (2022-03-01)

Management of Severe Asthma in Eosinophilic Granulomatosis with Polyangiitis with Interleukin-5-Targeted Therapies: Current Status and Report of Two Cases
by: Ciro Romano, et al.
Published: (2022-11-01)

Severe mononeuritis multiplex in a patient with eosinophilic granulomatosis with polyangiitis
by: Desislava Kalinova, et al.
Published: (2019-10-01)

Eosinophilic Cholecystitis Associated with Eosinophilic Granulomatosis with Polyangiitis
by: Hiroyuki Ito, et al.
Published: (2020-12-01)

Rapid effect of benralizumab in exacerbation of severe eosinophilic asthma associated with eosinophilic granulomatosis with polyangiitis
by: Carlos Martínez-Rivera, et al.
Published: (2021-01-01)

ANCA-negative eosinophilic granulomatosis with polyangiitis in a girl misdiagnosed as asthma and pulmonary tuberculosis
by: Fang Yang, et al.
Published: (2023-06-01)

Successful treatment with rituximab and plasmapheresis of renal involvement of eosinophilic granulomatosis with polyangiitis
by: Ryuichi Yoshii, et al.
Published: (2023-02-01)

Wells’ syndrome associated with eosinophilic granulomatosis with polyangiitis − A case report
by: Radević Tatjana, et al.
Published: (2021-01-01)

Eosinophilic Granulomatosis with Polyangiitis and Diffuse Gastrointestinal Involvement
by: Diana L. Franco, et al.
Published: (2014-10-01)

Granulomatosis with polyangiitis
by: Zubayer Ahmad, et al.
Published: (2016-12-01)

Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report
by: Isao Suzaki, et al.
Published: (2023-04-01)

Acute heart failure with left ventricular thrombus in the course of eosinophilic granulomatosis with polyangiitis
by: Anna Masiak, et al.
Published: (2014-07-01)

THE 2015 INTERNATIONAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS
by: T. V. Beketova, et al.
Published: (2016-07-01)

COVID-19 in a Patient Treated for Granulomatosis with Polyangiitis: Persistent Viral Shedding with No Cytokine Storm
by: Pascale Daniel, et al.
Published: (2020-09-01)

A diagnostic score for eosinophilic granulomatosis with polyangiitis among eosinophilic disorders
by: Hideyuki Takahashi, et al.
Published: (2023-04-01)

Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series
by: Aikaterini Detoraki, et al.
Published: (2021-06-01)

Stellate ganglion block as an intervention in refractory eosinophilic granulomatosis with polyangiitis: a case report
by: Danxu Ma, et al.
Published: (2022-02-01)

Current approaches to diagnosing and treating eosinophilic granulomatosis with polyangiitis: The 2015 international guidelines
by: T V Beketova, et al.
Published: (2016-05-01)

Eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome) as a differential diagnosis of hypereosinophilic syndromes
by: Yuri Albuquerque Pessoa Santos, et al.
Published: (2017-01-01)

Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi
by: Sei Adachi, et al.
Published: (2022-02-01)

Multiple cerebral infarction diagnosed as Eosinophilic Granulomatosis with Polyangiitis by autopsy
by: Kenichiro Hira, et al.
Published: (2019-11-01)

A case of hemodialysis and steroid therapy for carbamazepine-induced eosinophilic granulomatosis with polyangiitis: a case report with literature review
by: Tetsuya Abe, et al.
Published: (2020-05-01)